Welcome to our dedicated page for McKesson Corporation news (Ticker: MCK), a resource for investors and traders seeking the latest updates and insights on McKesson Corporation stock.
McKesson Corporation (symbol: MCK) is a leading healthcare services and information technology company, dedicated to improving the business of healthcare globally. Ranked 11th on the Fortune 500 list, McKesson collaborates with a diverse range of stakeholders including payers, hospitals, physician offices, pharmacies, pharmaceutical companies, and other entities across the healthcare spectrum. The company's mission is to foster healthier organizations that deliver superior care to patients in every setting.
McKesson is one of the top three pharmaceutical wholesalers in the United States, engaging in the sourcing and distribution of branded, generic, and specialty pharmaceutical products. Their extensive client base includes retail chains, independent pharmacies, mail-order pharmacies, hospital networks, and healthcare providers. Alongside Cencora and Cardinal Health, McKesson commands over 90% of the US pharmaceutical wholesale industry.
Beyond the US, McKesson's reach extends to Canada, where they are involved in pharmaceutical wholesale and distribution. Additionally, McKesson supplies medical-surgical products and equipment to healthcare facilities and offers a range of technology solutions tailored for pharmacies.
McKesson's comprehensive service offerings include pharmaceutical and medical-surgical supply management, healthcare information technology solutions, and business and clinical services. The company is committed to helping its customers enhance their financial, operational, and clinical performance, ultimately aiming to deliver better patient care.
Recent achievements include strategic partnerships and innovative projects that continue to position McKesson as a key player in the healthcare industry. Their ongoing projects are designed to streamline operations and improve efficiency across the board, ensuring that healthcare providers can focus on patient care.
For more details on McKesson Corporation, visit www.mckesson.com.
McKesson Corporation (NYSE: MCK) has announced plans to sell its UK businesses to AURELIUS as part of its strategy to fully exit the European market. This includes the sale of entities like LloydsPharmacy and AAH Pharmaceuticals. The transaction is set to close in fiscal 2022, pending regulatory approvals. CEO Brian Tyler emphasized that this move allows for better long-term growth opportunities for the UK operations while enabling McKesson to focus on strategic investments outside Europe. This sale follows a previous agreement to divest businesses in several European countries.
The Board of Directors of McKesson Corporation (NYSE:MCK) has declared a regular dividend of 47 cents per share of common stock. This dividend will be payable on January 3, 2022, to stockholders of record as of December 1, 2021. This announcement highlights McKesson's commitment to returning value to its shareholders while maintaining its position as a leader in healthcare supply chain management and services.
Hercules Capital has appointed Pam Randhawa to its Board of Directors, effective November 1, 2021. With over 20 years in the healthcare and life sciences sectors, her background includes leadership positions at McKesson and her own firm, Empiriko Corporation. Randhawa's expertise is expected to enhance the board's capabilities as Hercules focuses on long-term growth and shareholder returns. CEO Scott Bluestein praised her contributions within the life sciences community, indicating her appointment is part of a strategy to bolster the company's leadership team.
AmerisourceBergen (ABC), Cardinal Health (CAH), and McKesson (MCK) have settled opioid-related claims with the Cherokee Nation for approximately $75 million over 6.5 years. This agreement resolves ongoing litigation and allows the companies to focus on safe medication delivery. The settlement is part of broader negotiations with federally recognized Native American tribes, despite the companies disputing the allegations against them. The firms emphasize their commitment to addressing the opioid epidemic's impact on communities.
McKesson Corporation (NYSE: MCK) is set to release its second quarter fiscal 2022 financial results on November 1, 2021, after market close. The earnings conference call will take place at 4:30 PM Eastern Time, which will be available via a live webcast on McKesson's Investor Relations website. Investors can access the earnings press release, financial tables, and slide presentation online following the conference.
McKesson Corporation (NYSE:MCK) announced the election of Dr. Richard H. Carmona as an independent director, effective Sept. 6, 2021. Dr. Carmona brings extensive healthcare experience, including his role as the 17th Surgeon General of the United States. He aims to improve public health access, reflecting McKesson's mission to enhance care across various settings. The board chair, Edward Mueller, expressed confidence in Dr. Carmona’s contributions to the company's future direction.
AmerisourceBergen (ABC), Cardinal Health (CAH), and McKesson (MCK) announced progress on the opioid claims settlement involving U.S. states and territories. As of August 21, 2021, 42 states, 5 territories, and Washington, D.C. have joined the settlement, allowing the process to move forward. This next phase includes a 120-day period for political subdivisions to join, ending January 2, 2022. If enough subdivisions participate, the settlement will take effect 60 days after that. The companies aim to focus on secure medication delivery while providing relief to affected communities.
McKesson Corporation (NYSE:MCK) has announced an upcoming Investor Day scheduled for December 8, 2021, in New York City. Interested stakeholders can access a live audio webcast along with presentation slides via the company's Investor Relations website. McKesson is recognized as a global leader in healthcare supply chain management and has received accolades such as being named a Most Admired Company by FORTUNE and a Best Place to Work by the Human Rights Campaign Foundation.
McKesson Corporation (NYSE: MCK) announced its fiscal 2022 first-quarter financial results on August 4th. Investors can review the results on McKesson’s Investor Relations website. A live earnings conference call will be held today at 4:30 PM ET, with a replay available for twelve months. McKesson is recognized as a leader in healthcare supply chain management and has received accolades including 'Most Admired Company' in the healthcare wholesaler category by FORTUNE. Visit www.mckesson.com for more information.
The Board of Directors of McKesson Corporation (NYSE:MCK) declared a regular dividend of $0.47 per share on July 23, 2021, marking a 12% increase from the previous quarter's $0.42. This dividend will be payable on October 1, 2021 to stockholders on record as of September 1, 2021. McKesson is recognized as a leader in healthcare supply chain management and has received accolades such as being a 'Most Admired Company' in the healthcare wholesaler category by FORTUNE.
FAQ
What is the current stock price of McKesson Corporation (MCK)?
What is the market cap of McKesson Corporation (MCK)?
What services does McKesson Corporation provide?
Where does McKesson Corporation operate?
Who are McKesson's primary clients?
What makes McKesson a leading pharmaceutical wholesaler?
How does McKesson help improve healthcare delivery?
What are some recent achievements of McKesson Corporation?
Can individuals buy products directly from McKesson?
How does McKesson contribute to the healthcare industry?
What is the significance of McKesson's partnerships?
Where can I find more information about McKesson Corporation?
